Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
PFE:NYSE
Pfizer Inc
$26.67
-0.41%
(-0.11) 1D
$26.65
-0.07% (-0.020)
Pre-market
Closed: Apr 23, 4:01:43 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PFE...
Open
$26.76
High
$26.83
Low
$26.38
Mkt. cap
151.71B
Avg. vol.
37.12M
Volume
15.28K
Dividend
6.45%
Quarterly dividend
$0.43
Ex dividend date
Jan 23, 2026
P/E ratio
19.67
52-wk high
$28.74
52-wk low
$21.97
EPS
$1.36
Beta
0.43
Shares outstanding
5.69B
No. of employees
75K
News stories
From sources across the web
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer Inc
CEOAlbert Bourla
Employees75K
Founded1849
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitepfizer.com
Next call in 11 days
Tue, May 5, 10:00 AM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (0.72 est.)USD
Revenue / Estimate
-/ (13.81B est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
13.72B
14.65B
16.65B
17.56B
Cost of goods sold
2.59B
3.50B
3.98B
5.06B
Cost of revenue
2.59B
3.50B
3.98B
5.06B
Research and development expenses
2.18B
2.44B
2.49B
3.32B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.91B
3.29B
3.08B
3.74B
Operating expense
6.30B
6.95B
6.80B
8.29B
Total operating expenses
8.89B
10.45B
10.78B
13.35B
Operating income
4.82B
4.20B
5.88B
4.20B
Other non operating income
103.00M
121.00M
181.00M
1.35B
EBT including unusual items
2.78B
3.04B
3.33B
-1.64B
EBT excluding unusual items
4.45B
3.83B
5.54B
5.09B
Income tax expense
-189.00M
141.00M
-216.00M
-2.00M
Effective tax rate
-6.79%
4.63%
-6.48%
0.12%
Other operating expenses
-
-
-
-
Net income
2.97B
2.91B
3.54B
-1.65B
Net profit margin
21.63%
19.86%
21.26%
-9.39%
Earnings per share
0.92
0.78
0.87
0.66
Interest and investment income
182.00M
156.00M
138.00M
247.00M
Interest expense
-654.00M
-654.00M
-652.00M
-711.00M
Net interest expenses
-472.00M
-498.00M
-514.00M
-464.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
6.44B
5.82B
7.53B
5.86B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer